2' 0 ' *()+'organic/edures/edures6.pdfqxa 6o .ö lÓ " ×h n ¹ y ðm 6h hrr q 6...
TRANSCRIPT
'
'
'
'
��������2'
��0��'
'
*()+''
'
'
'
����5��� ��2��0�!4&�-/,'
��"�5"���2#� %1��.3'
'
'
'
'
'
'
'
'
'
�������$��"����'
�������'
��������'
' '
'
:(
( )
:
( : :
:
: (
(
: ( (
(
: :
:
(
: : ( : (
:
: :
: (
(
(
(
:
X tetrodotoxin X tagtitoxin
T FARI X
X
X X
X
X X
N
HN
OH
HOOHH2N
O
O
H
HOO
OH
tetrodotoxin (TTX) tagetitoxin
O
OPO3H-
S
COOH
+H3N
AcO
OHH2N
O
S
N
HO
N
S
COOH
HOO
5
OH
OH
H
HO
O
HHOHO
OHO
OHHO
HO
O
ouabainluciferin FARI
O
Onepetalactone
OO
O O
OO
OMe
oscillatoxin D (OTX-D)
OH
15
11
1
4
7
physalin Aa bitter principle of Physalis alkekengi
O
H
O OO
OOOH
O
HO
O
H
HOO
OHO chaxine Bsteroidal compound
fron an edible mushroom
HN
N NH
HN
O
H2NNH2
H2N
O
OHOH
HN
NH O
H2N
O
OMe 7
crambescin B COOH saxitoxin (STX)
NH
O
OH
O
OH
H
sespendole
NN
O
NH
NH2
NH2
peramine
p
6
h 6 m ( k
s e k X r a
R -D D k X ) R F
k k
k X i R k r a Q
6km h T R X k r Im k
6 k r
6
k k 6 R gL hR
X r aR k m rrg 6 R T
at k r R Qu Q
r k r k Q T 6
h R X o r Im
k p
r r
N
HN
OH
HO
OHH2N O
O
H
HO
5H
5-deoxyTTX (from puffer)
N
HN
OH
HOHH2N
OO
OHO
H OH
8-deoxyTTX(unnatural)
O
NH
O
COCCl3
common intermediate
HO OH
N
HN
OH
HOOHH2N
OO
OHO
OHH
tetrodotoxin (from puffer)
8
N
HN
OH
HOOHH2N
OO
OHO
COOOH
NH3
H
chiriquitoxin (from frog)
bromolevoglucosenone
O
O
O
H H
R Br
N
HN
CH3
OH
HOOHH2N
OO
OHO
H11
11-deoxyTTX (from puffer)
8N
HN
CH3
OH
OHH2N OO
OHO
H H11
8,11-dideoxyTTX(unnatural)
N
HN
CH3
OH
HOOHH2N O
O
H
HO
115H
5,6,11-trideoxyTTX (from puffer)
R = HR = OTBDPS
11
O
NH
O
COCCl3
5,11-dideoxyTTX(from newt)
N
HN
CH3
H
HOOHH2N O
O
H
HOH
Q X a 6 h
m 6 h h r R
Q k R 6k X R
X r a u X a m 6 R gL h
g Im 6k k 6
h k 6 t t r
k km h
a RL r k a o k g
X h u g Q g 6 R
Qm k k r r gm 6
g 6Ri k Q h r
2. tagtitoxin (Tgt)m 1981 k Pseudomonus syringase pv. Tagetis Q
X a g RAN RNAP
r Tgt m h k e RNAP RNAPIII
k ueat h r Q Tgt
m 1981 k X RX r R r k k
r gm hg k
r
rgk X a Tgt m
N
HN
OH
HOOHH2N
O
O
H
HOO
OH
tetrodotoxin (TTX)
N
HN
OH
HOOHH2N
O
H
HO
OH
OH
N
HNH2N
HOH
Cep-21010-hemiketal-TTX
S
COOHHO
OHCOOH
OPO3HH3N
AcO
HO O
S
H
OPO3H
HOOCCOOH
OH
H
NH NH3
AcO
NH3
HO3PO
HOOC H
S OHCONH2
OAc
201619891981
m k r
k k h n
hR r m (
k k X
h X r Q
R k µ
h R k Q i
r k QkX r gm
k r k k r h
t t r
k r
N
actinidine
O
O
O
OH
nepetalactolnepetalactone
O
O
iridomyrmecin
O
O
iso-iridomyrmecin
O
O
O
O
dihydronepetalactone
isodihydronepetalactone
PhNHMe
O
N HPh
CHO
O
H
(S)-citronellal
O
OH
O
H
dihydronepetalactone
h D 7A D m
h k r Q
Ri k Q T Q r g a Im
� 1 7 D7 3 h k
2Q t g 40 Q 9
Qk r a ra k 40
R h 40m T R
gL h Qk r a 40
h r
� 1 7 D7 3
�����������������
� i i Q m
s Q u eQ r m J Q eQ a
h g
.-2 h n r n Q R
Q eQ r ra R e
R a Q
R Q .-2 h X r Q .-2 m
E9 Q g at R h X au m Q QL r
.-2 TR Q eQ hm
hg Q Ri k .-2 Q h
g i T R r X r gm
.-2 r n .-2 h n
.-2 e
hg k hhuk T
h r �
�
( �
m h
R h k
h r 2 2
h n m TQ T
T X r a rgk
R Qk ra
Q i k R Qke
µ R Q r a Q
Ri k Q m k r r
u Qk r
gm h g k r
m gL hR Q h -
g g g R R
h 8 Q k
k h r
8
O
O
COOHH2N
HS+
S
N
HO S
N COOH
NH4OAcbuffer (30 °C, 3 h)
O2
0.30 ± 0.24 %
OH
H
HHO
19-norbufalin
HH
H
O
O
HO
HOOH
H
H
OH
proposed structure of Inagami-Tamura EDLF
OH x 2
OH
OH
H
HO
O
HHOHO
OH
ouabain
O
O
OHHO
HO
x x x x
x t x .
y va a r c
a r v tir r sy x w
w x x v
i l ts x irb i l s
sy x : t s x
x v x ptir
: x
w x
tir v y t
x x v tir r
px v or lx y r
th r sy x x w
x i px v w
i i
w x
x w or
HN
OO
O
CCl3[HO]
guanidine
carbamate
deprotection
site-selectivehydroxylation
N
HN
OH
HOOHH2N
OO
OHO
OHH
tetrodotoxin
isonitrile
HNHN
NHN
OH
NH2
HO
H2N
STX skeleton
A
C
HNN3
HO
NH2
CbzN
HN
NCbzN
N3
OBrBr
6
5
HN
NCbzN
HN
NHCbz
NCbz
OH
H
O
O
NBoc
OH
OTBS
O
NBoc CHO
HMPA
toluene-78 ºC
OTBS
Li
>10:1
OMs
Br+
B(TFA)3
THF
0 x w i a 1EII BANED x
s w x v
t wi i (
w 1 5 x
w x
x v x c x t 1 7
1P EJO E HER , LL, -
o w x
y x t
i t r i o
s a sw x w y t u
sy x x x o v
i w i i )
x
y w or h
s a w h
crambescin B carboxylic acid
HN
NH O
H2N
O
OMe
HN
NH O
CbzN
OAcMe
BrBr
HN
NH2CbzN
OAcMe
HO
N
TBDPSO
9
CbzNNHBoc
9
9MeO
HO
9Me
HO
9Me
9 PyHBr3 K2CO3
CH2Cl2-H2O
(73%)
(R,R)-salan ligand Ti(O-iPr)4, WXR
30% H2O2, CH2Cl2
3 steps
Pd(PPh3)4InI, formalin
4 steps
+3 steps
(i) N-alkynylation(ii) 6-endo cyclization
NNH2
O
R
NN
O
RH
NH HN
O
R
X3
NN
O
NH
NH2
NH2
peramine
v or sy t
w w w s
x w i C KNN CKPLIHJF t o
w or 01 t s
x
( x t .
. 0 1 ASHJE 0 tlx y w
or F KCTBE C ASHJFP h
s 0 a h r t 12 a ir w x
v v or x
x ta h i a gc i
v lx y wvor
w x
NH
O
OH
O
OH
H
sespendole
A BC D
E31
OTBS
OTMS
H
NO2
O
OHOTf
HO
+NH2
O
OH
O
OH
HOR
NO2
OHC OH
O
OE
D
Wieland-Miescher's ketone
cascadereaction
Sonogashiracoupling
aromatic segment terpene segment
E
DE
D
A A
A
12 steps 23 steps
OH
RH
H
OH
RH
H
tachysterol
O
H
HOO
OHO
H
HHO
ergosterol
OO
O
RH
HOO
OH
chaxine B(revised structure)
OH
RH
HOhv (254 nm)OO
WX-R/CH2Cl2
1) DBU CH2Cl2
2) TMSOTf AW-300 CH2Cl2
MCPBA
OO
CH2Cl2
silica gel
1)
2)
1) TBHP VO(acac)2
2) silica gel
BB(revised structure)
O
H
HOO
OHO
sy x i lx w or
v i i x w or
i v tir x
vu ir
p o x x 66
x xt ( , LL
. 1
y h x s
x v y 1 81
x w ta wvor 2x y t u
r sy x ts
Xt h r v ir Xy
w rx a h t sw
1 2tlx x w ir ,
x
) x x
w h wy tir
s v or xndsvc x v x
tir h r x wy
v t v e DE JK K
x a sy v
OO
O O H
OHO
OH
Me O
OMe
aplysiatoxin (ATX)
OO
O O
OR
O
OMe
oscillatoxin D
30
15
111
4
7
O
OMe
O
O
O
OMe
common intermediate
CHO
OMe
MgBr
14 steps
R
HO
HO
HO
Br
ORO
OO O
Me
OH2
OR
HO
RO O
w x DE JK K w d x o i
i - y rx w x tv
ir p
x a s w or x 3294 x
i i tir
x i
y p x
2 6 t w
1 Nishikawa, T.; Urabe, D.; Adachi, D.; Isobe, M. Synlett 2015, 26, 1930-1939. 2 Nishikawa, T.; Isobe, M. Chem. Rec. 2013, 13, 286-302. DOI: 10.1002/tcr.201200025 3 (a) Sawayama, Y.; Nishikawa, T. Angew. Chem. Int. Ed. 2011, 50, 7176-7178. DOI:
10.1002/anie.201102494 (b) Ueno, S.; Nakazaki, A.; Nishikawa, T. Org. Lett. 2016, 18, 6368-6371, 2016. DOI: 10.1021/acs.orglett.6b03262
4 (a) Nakazaki, A.; Ishikawa, Y.; Sawayama, Y.; Yotsu-Yamashita, M.; Nishikawa, T. Org. Biomol. Chem. 2014, 12, 53-56. DOI: 10.1039/c3ob42017e (b) Nakazaki, A.; Nakane, Y.; Ishikawa, Y.; Yotsu-Yamashita, M.; Nishikawa, T. Org. Biomol. Chem. 2016, 14, 5304-5309. DOI: 10.1039/C6OB00914J (c) Tsukamoto, T.; Chiba, Y.; Nakazaki, A.; Ishikawa, Y.; Nakane, Y.; Cho, Y.; Nishikawa, T.; Yotsu-Yamashita, M.; Wakamori, M.; Konoki, K. Bioorg. Med. Chem. Lett. 2017, 27, 1247-1251. DOI: 10.1016/j.bmcl.2017.01.054
5 (a) Yamamoto, Y.; Nakazaki, A.; Nishikawa, T. Tetrahedron 2017, 73, 3443–3451. DOI: 10.1016/j.tet.2017.05.004. (b) Ito, S.; Yamamoto, Y.; Nishikawa, T. Biosci. Biotechnol. Biochem. 2018, 82, 2053-2058. (DOI: 10.1080/09168451.2018.1511966)
6 (a) Sugino, K.; Nakazaki, A.; Isobe, M.; Nishikawa, T. Synlett 2011, 647-650. DOI: 10.1055/s-0030-1259551 (b) Adachi, M.; Higuchi, K.; Thasana, N.; Yamada, H.; Nishikawa, T. Org. Lett. 2012, 14, 114-117. DOI: 10.1021/ol202895u (c) Ono, Y.; Nakazaki, A.; Ueki, K.; Higuchi, K.; Sriphana, U.; Adachi, M. Nishikawa, T. J. Org. Chem. 2019, 84, 9750-9757. DOI: 0.1021/acs.joc.9b01597
7 Hirata, Y.; Nakazaki, A.; Kawagishi, H.; Nishikawa, T. Org. Lett. 2017, 19, 560-563. DOI: 10.1021/acs.orglett.6b03724
8 Nokura, Y.; Araki, Y.; Nakazaki, A.; Nishikawa, T. Org. Lett. 2017, 19, 5992-5995. DOI: 10.1021/acs.orglett.7b03032
OH
OH
H
HO
O
HHOHO
OHO
OHHO
HO
ouabain(cardiotonic steroid)
O
HO
HOOH
H
H
OH
proposed structue of Inagami-Tamura EDLF
(estrogenic steroid)
OH x 2OH
OH
H
OH
HO
O
OH
OH
HO
O
OHOH
OH
OH
R
Mizoroki-Heckreaction
– CO2
R
H H
H
OH
H OH
OH
OO
H
estrogenic compound
cardiotonic steroidal compound
IMDAreaction
IntramolecularDiels-Alder (IMDA)
reaction
key intermediates
9 (a) Nakazaki, A.; Hashimoto, K.; Ikeda, A.; Shibata, T.; Nishikawa, T. J. Org. Chem. 2017, 82, 9097-9111.
DOI: 10.1021/acs.joc.7b01640 (b) Watanabe, S.; Nishikawa, T.; Nakazaki, A. Org. Lett. 2019, 21, 7410-7414. DOI: 10.1021/acs.orglett.9b02716
�&?+ 28
Synthetic Study on Lycojapodine A A
29
30
�&?+ 28
Inagami-Tamura EDLF ( )
A
29
Oscillatoxin D Aplysiatoxin
8
30
RCAI-56 α-
Pd 0
B
�-?+ 28
A
Crambescin
29
Plumisclerin A A
Chaxine 19-
30 A
petromyzestrosterol
CA 28 (JT))
) ) MST
29
30 ) )OAT ) ) ) )
%� +� (1) Bian, L.; Cao, S.; Cheng, L.; Nakazaki, A.; Nishikawa, T.; Qi, J. Semi-synthesis and
Structure-Activity Relationship of Neuritogenic Oleanene Derivatives. ChemMedChem 2018, 13, 1972-1977. (DOI: 10.1002/cmdc.201800352)
(2) Huang, Y.; Nishikawa, T.; Nakazaki, A. Toward a synthesis of fawcettimine-type Lycopodium alkaloids: stereocontrolled synthesis of a functionalized azaspirocycle precursor. J. Org. Chem. 2018, 83, 11108-11117. (DOI: 10.1021/acs.joc.8b01719)
(3) Qi, J.; Cheng, L.; Sun, Y.; Hirata, Y.; Ushida, N.; Ma, Z.; Osada, H.; Nishikawa, T.; Xiang. L. Identification of an Asexual Reproduction Inducer of Phytopathogenic and Toxigenic Fusarium. Angew. Chem. Int. Ed. 2018, 57, 8100-8104. (DOI: 10.1002/anie.201803329)
(4) Damnjanovic, J.; Matsunaga, N.; Adachi, M.; Nakano, H.; Iwasaki, Y. Facile Enzymatic Synthesis of Phosphatidylthreonine Using an Engineered Phospholipase D. Eur. J. Lipid Sci. Technol. 2018, 120, 1800089-1800095. (DOI: org/10.1002/ejlt.201800089)
(5) Ito, S.; Yamamoto, Y.; Nishikawa, T. A concise synthesis of peramine, a metabolite of endophytic fungi. Biosci. Biotechnol. Biochem. 2018, 82, 2053-2058. (DOI: 10.1080/09168451.2018.1511966)
(6) Adachi, M.; Miyasaka, T.; Kudo, Y.; Sugimoto, K.; Yotsu-Yamashita, M.; Nishikawa, T. Total Syntheses and Determination of Absolute Configurations of Cep-212 and Cep-210, Predicted Biosynthetic Intermediates of Tetrodotoxin Isolated from Toxic Newt. Org. Lett. 2019, 21, 780-784. (DOI: 10.1021/acs.orglett.8b04043)
���91�<�
(1) 8 vol.101 2018 3 pp45.
(2) 26 )
2018 pp104-107.
(3) 2 2 II - 2
- 64 2018 pp107-112.
(4) )
CSJ Current Review 272018 pp86-93.
!E�������4:
(1) D)30 6
2018.6.1-2018.6.2.
(2) (
113 2018 2018.6.6-2018.6.7.
(3) ) ) ) Aplysiatoxin 1132018 2018.6.6-2018.6.7.
(4) ) ) ) ) 113 2018.6.6-2018.6.7.
(5) 302018.6.30.
(6) ) α 2018.7.20.
(7) ) ) ) RCAI-56 α- 2018 2018.7.26-2018.7.27.
(8) C-N 2018.7.30.
(9) C-N 2018.7.31.
(10) 8
1 2018.8.16-2018.8.17.
(11) Masato Kasuga, Clyde Gorapava Puilingi, Atsuo Nakazaki, Shunsuke Tsunogae, Yuko Cho, Keiichi Konoki, Mari Yotsu-Yamashita: Screening for bioactive compounds in marine organisms collected in the Solomon Islands. Tohoku University's Chemistry Summer School 2018 (Sendai) 2018.8.27-2018.8.28.
(12) ) ) 2- 8 Diels-Alder
48 2018.9.3-2018.9.5.
(13) ) )
183 2018.9.15.
(14) ) ) ) ) ) Chaxine183 2018.9.15.
(15) ) ) ) ) ) ) Oscillatoxin D 60 2018.9.26-2018.9.28.
(16) ) ) ) ) ) ) ) )
) ) ) ) ) )
602018.9.26-2018.9.28.
(17) ) ) B 492018.11.3-2018.11.4.
(18) ) ) 19-norbufalin 49
2018.11.3-2018.11.4.
(19) Diels-Alder 8
2018.11.7-2018.11.8.
(20) 5 in2019.11.9.
(21) Toshio Nishikawa, Misaki Niki, Yushi Hirata, Atsuo Nakazaki, Hidenori Kawagishi : Collective Synthesis of Chaxines, Novel Steroidal Natural Products Isolated from Chinese Edible Mushroom. The 14th International Kyoto Conference on New Aspect of Organic Chemistry (Kyoto, Japan) 2018.11.12-2018.11.16.
(22) Yusuke Hanaki, Yusuke Araki, Yoshihiko Nokura, Atsuo Nakazaki, Masaki Kita, Kazuhiro Irie, Toshio Nishikawa: Synthetic studies on oscillatoxin D and its analogs. The 4th International Kyoto Conference on New Aspect of Organic Chemistry (Kyoto, Japan) 2018.11.12-2018.11.16.
(23) Toshio Nishikawa: Towards a Unified Synthesis of Aplysiatoxin and oscillatoxin Famile. The 4th International Symposium on Middle Molecular Strategy (ISMMS-4) 2018.11.30-2018.12.1.
(24) Yoshiki Nakane, Atsuo Nakazaki, Toshio Nishikawa: Synthetic Studies on chartelline C.
2018 2019.1.9.
(25) Yushi Hirata, Toshio Nishikawa: Synthetic studies on brachialactone, a novel nitrification inhibitor.
2018 2019.1.9.
(26) Yuuta Yamamoto, Toshio Nishikawa: Synthetic studies on conidiogenone, a strong conidiogenesis inducer of fungi.
2018 2019.1.9.
(27) Yusuke Araki, Toshio Nishikawa Synthetic Studies on Physalins 2018
2019.1.9. (28) Shogo Watanabe, Toshio Nishikawa, Atsuo Nakazaki: A new synthetic approach to cardiotonic st
eroids. 2018 2019.1.9.
(29) Tadaaki Tsukamoto, Yukie Chiba, Shunsuke Tsunogae, Tomoshi Yamada, Yuko Cho, Ryo Sakakibara,
Takuya Imazu, Shouta Tokoro, Yoshiki Satake, Yuki Ishikawa, Yoshiki Nakane, Masaatsu Adachi, Atsuo Nakazaki, Toshio Nishikawa, Minoru Wakamori, Mari Yotsu-Yamashita, Keiichi Konoki: Sensitivity of the voltage-gated sodium channel subtypes, Nav1.1 to Nav1.7, against guanidine-containing natural products and their analogues. The 1st International Symposium on Chemical Communication (ISCC2019) (Tokyo) 2019.1.9-2019.1.10.
(30) ) ) ) ) ) ) ) Oscillatoxin D 2019 2019.3.24-2019.3.27.
(31) ) ) Chartelline C 20192019.3.24-2019.3.27.
(32) ) ) ) ) ) 2019
2019.3.24-2019.3.27. (33) ) ) 2- Diels-Alder
2019 2019.3.24-2019.3.27.
(34) ) ) ) RCAI-56 α-2019 2019.3.24-2019.3.27.
(35) ) ) Pd 0
2019 2019.03.24-2019.03.27.
(36) ) ) ) B2019 2019.3.24-2019.3.27.
(37) ) ) ) ) ) Chaxine2019 2019.03.24-2019.03.27.
(38) ) ) 19- 2019
2019.3.24-2019.3.27.
(39) ) ) A2019 2019.3.24-2019.3.27.
(40) ) ) ) ) ) ) ) )
2019 2019.3.24-2019.3.27.
(41) )Clyde Gorapava Puilingi) ) ) ) ) )
Nav 20192019.3.24-2017.3.27.
(42) ) ) 20191
2019.3.24-2019.3.27.
2=
(1) , 04562018JP2018-123363 2018 6 28
(2) , , , , ,
) )
WO/2018/155720 PCT/JP2018/007360 2018 8 30
�������
(1) 2018.5.14.
@
(1) 113 2018 . 2018.6.7.
(2) IGER Annual meeting 2018 Poster Award. 2019.1.9.
(3) 2019 . 2019.3.24.
(4) 2019 . 2019.3.26.